Factors related to the use of bone densitometry: Survey responses of 494 primary care physicians in New England

Osteoporosis International

Volumn 14, Issue 2, 2003, Pages 123-129

  Solomon, D H ^a   Connelly, M T ^b   Rosen, C J ^c   Dawson Hughes, B ^d   Kiel, D P ^e   Greenspan, S L ^f   Leib, E S ^g   Holick, M ^h   Miguel, A H ⁱ   Finkelstein, J S ^j  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD PILGRIM HEALTH CARE   (United States)

^c Maine Osteoporosis Center   (United States)

^d TUFTS UNIVERSITY   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF VERMONT   (United States)

^h BOSTON UNIVERSITY MEDICAL CENTER   (United States)

ⁱ Proctor and Gamble Pharmaceuticals   (United States)

^j MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

Bone mineral densitometry; Osteoporosis; Primary care

Indexed keywords

CALCIUM; VITAMIN D;

AGED; BONE DENSITOMETRY; BONE DENSITY; BONE SCINTISCANNING; CLINICAL PRACTICE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; EDUCATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; GEOGRAPHY; HEALTH SURVEY; HUMAN; INTERNAL MEDICINE; MALE; OSTEOPOROSIS; PATIENT CARE; PHYSICIAN; POSTMENOPAUSE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; TRAINING;

BONE DENSITY; CROSS-SECTIONAL STUDIES; DENSITOMETRY, X-RAY; FAMILY PRACTICE; HUMANS; MIDDLE AGED; NEW ENGLAND; ODDS RATIO; OSTEOPOROSIS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; QUESTIONNAIRES; REFERRAL AND CONSULTATION;

EID: 1642317327     PISSN: 0937941X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00198-002-1326-7     Document Type: Review

References (32)

1. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996;312:1254-9.
2. Kanis JA, WHO Study Group. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994;4:369-81.
3. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6.
4. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the Fracture Intervention Trial. JAMA 1998;280:2077-82.
5. Reginster JY, Minne HW, Sorensen OH, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Osteoporos Int 2000;11:83-91.
6. Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997;337:1641-7.
7. Chesnut CH, Silverman S, Andriano K, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. Am J Med 2000;109:267-76.
8. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001;344:1434-41.
9. Phillipov G, Mos E, Scinto S, Phillips PJ. Initiation of hormone replacement therapy after diagnosis of osteoporosis by bone densitometry. Osteoporos Int 1997;7:162-4.
10. Silverman SL, Greenwald M, Klein RA, Drinkwater BL. Effect of bone density information on decisions about hormone replacement therapy: a randomized trial. Obstet Gynecol 1997;89:321-5.
11. Rubin SM, Cummings SR. Results of bone densitometry affect women's decisions about taking measures to prevent fractures. Ann Intern Med 1992;116:990-5.
12. Marci CD, Viechnicki MB, Greenspan SL. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 2000;66:113-8.
13. Solomon CG, Connelly MT, Collins K, Okamura K, Seely EW. Provider characteristics: impact on bone density utilization at a health maintenance organization. Menopause 2000;7:391-4.
14. Sheehan J, Mohamed F, Reilly M, Perry IJ. Secondary prevention following fractured neck of femur: a survey of orthopedic surgeons practice. Irish Med J 2000;93:105-7.
15. Schrager S, Kausch T, Bobula JA. Osteoporosis risk assessment by family practice faculty and residents: a chart review. West Med J 1999;98:34-6.
16. Hajcsar EE, Hawker G, Bogoch ER. Investigation and treatment of osteoporosis in patients with fragility fractures. Can Med Assoc J 2000;163:819-22.
17. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320-3.
18. Mallmin H, Ljunghall S, Persson I, Naessen T, Krusemo UB, Bergstrom R. Fracture of the distal forearm as a forecaster of subsequent hip fracture: a population-based cohort study with 24 years of follow-up. Calcif Tissue Int 1993;52:269-72.
19. American Medical Association Master File. Chicago, IL: AMA, 2000.
20. Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: Wiley, 2000:162.
21. SAS Institute, Inc. SAS software, changes and updates through release 6.11. Cary, NC: SAS, 1996.
22. Torgerson DJ, Thomas RE, Campbell MK, Reid DM. Randomized trial of osteoporosis screening: use of hormone replacement therapy and quality of life results. Arch Intern Med 1997;157:2121-5.
23. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis. Br J Obstet Gynecol 1992;99:325-8.
24. Rozenberg S, Kroll M, Vandromme J, Paesmans M, Ham H. Effect of bone density evaluation on hormone replacement therapy prescription. Maturitas 1996;24:57-61.
25. Torgerson DJ, Donaldson D, Russell IT, Reid DM. Hormone replacement therapy: compliance and cost after screening for osteoporosis. Eur J Obstet Gynecol 1995;59:57-60.
26. Jones G, Scott F. Low bone mass in premenopausal parous women: identification and the effect of an information and bone density feedback program. J Clin Densitom 1999;2:109-15.
27. Jamal SA, Ridout R, Chase C, Fielding L, Rubin LA, Hawker GA. Bone mineral density testing and osteoporosis education improve lifestyle behaviors in premenopausal women: a prospective study. J Bone Miner Res 1999;14:2143-9.
28. Davis D, O'Brien MAT, Freemantle N, Wolf FM, Mamanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health outcomes? JAMA 1999;282:867-74.
29. Oxman AD, Thomson MA, David DA, Haynes RB. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. Can Med Assoc J 1995;153:1423-31.
30. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990;263:549-56.
31. Werner P, Vered I. Management of osteoporosis: a survey of Israeli physicians' knowledge and attitudes. Isr Med Assoc J 2000;2:361-4.
32. Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis. A randomized trial. Ann Intern Med 1998;128:996-9.